The Trump administration is facing conflicting political pressures after Health Secretary Robert F. Kennedy Jr. said the Food and Drug Administration will "study" adding safety restrictions on abortion pills.
Why it matters: New limits like requiring in-person prescribing of the widely used abortion drug mifepristone would severely limit access to abortion in states with bans.